Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa

Journal of Medical Virology

Volumn 80, Issue 6, 2008, Pages 953-959

  Marais, Dianne J ^a   Passmore, Jo Ann S ^a   Denny, Lynette ^a   Sampson, Candice ^a   Allan, Bruce R ^a   Williamson, Anna Lise ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cervical; Comparison; HPV; Impact HIV infection; Oral

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 72; MAJOR CLINICAL STUDY; PREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VIRUS INFECTION; WART VIRUS;

ADULT; AFRICA, SOUTHERN; AGE DISTRIBUTION; ALPHAPAPILLOMAVIRUS; CERVIX UTERI; COHORT STUDIES; FEMALE; GENOTYPE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; MIDDLE AGED; MOUTH; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 43249091961     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21166     Document Type: Article

References (20)

1. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG. 2004. Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co-infection on HPV genotype distribution. J Med Virol 73:481-485.
2. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. 2005. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191:1808-1816.
3. Clifford GM, Goncalves MA, Franceschi S. 2006. Human papillomavirus types among women infected with HIV: A meta-analysis. AIDS 20:2337-2344.
4. D'souza G, Fakhry C, Sugar EA, Seaberg EC, Weber K, Minkoff HL, Anastos K, Palefsky JM, Gillison ML. 2007. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 121:143-150.
5. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur HH. 2004. Classification of papillomaviruses. Virology 324:17-27.
6. Fakhry C, D'souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, Gillison M. 2006. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol 44:4479-4485.
7. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa, Clemens SA, Dubin G. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 And 18: Follow-up from a randomised control trial. Lancet 367: 1247-1255.
8. Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, Reichman RC. 2006. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 194:428-434.
9. Marais D, Carrara H, Kay P, Ramjee G, Allan B, Williamson AL. 2006a. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. Virus Res 121:220-222.
10. Marais DJ, Sampson C, Jeftha A, Dhaya D, Passmore JA, Denny L, Rybicki EP, Van Der WE, Stephen LX, Williamson AL. 2006b. More men than women make mucosal Iga antibodies to human papillomavirus type 16 (HPV-16) and HPV-18: A study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 6:95.
11. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA. 2006. Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118:985-990.
12. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, Denny LE, Shapiro S, Williamson AL. 2006. HIV and preneoplastic and neoplastic lesions of the cervix in South Africa: A case-control study. BMC Cancer 6:135.
13. Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Fahrat S. 2004. Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents. J Infect Dis 190:1413-1421.
14. Parkin DM, Bray F. 2006. Chapter 2: The burden of HPV-related cancers. Vaccine 24:S11-S25.
15. Passmore JA, Marais DJ, Sampson C, Allan B, Parker N, Milner M, Denny L, Williamson AL. 2007. Cervicovaginal, oral, and serum Igg and Iga responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. J Med Virol 79: 1375-1380.
16. Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL. 2006. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 119:507-514.
17. Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, Connor M, Bull D, Newton R, Beral V. 2000. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88:489-492.
18. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
19. Syrjanen S. 2005. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32:59-66.
20. Williamson AL, Rybicki EP. 1991. Detection of genital human papillomaviruses by polymerase chain reaction amplification with degenerate nested primers. J Med Virol 33:165-171.